The store will not work correctly when cookies are disabled.
N-(2-chlorophenyl)quinoline-4-carboxamide
ID: ALA1078236
PubChem CID: 46882660
Max Phase: Preclinical
Molecular Formula: C16H11ClN2O
Molecular Weight: 282.73
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(Nc1ccccc1Cl)c1ccnc2ccccc12
Standard InChI: InChI=1S/C16H11ClN2O/c17-13-6-2-4-8-15(13)19-16(20)12-9-10-18-14-7-3-1-5-11(12)14/h1-10H,(H,19,20)
Standard InChI Key: GKTVWEKVHDFJJJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
3.2672 -7.6078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2774 -6.7808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0012 -6.3803 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5688 -6.3542 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5838 -5.5273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3121 -5.1302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3275 -4.3039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6205 -3.8838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8922 -4.2815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8803 -5.1064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1579 -5.5091 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3.2415 -9.2600 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9648 -8.8566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9787 -8.0270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5323 -8.8338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5474 -8.0144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8465 -7.5936 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1301 -7.9908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1190 -8.8132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8204 -9.2305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10 5 1 0
2 3 2 0
10 11 1 0
1 16 1 0
5 6 2 0
1 2 1 0
6 7 1 0
1 14 2 0
15 12 1 0
12 13 2 0
13 14 1 0
2 4 1 0
7 8 2 0
15 16 2 0
16 17 1 0
8 9 1 0
17 18 2 0
4 5 1 0
18 19 1 0
9 10 2 0
19 20 2 0
20 15 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 282.73 | Molecular Weight (Monoisotopic): 282.0560 | AlogP: 4.14 | #Rotatable Bonds: 2 |
Polar Surface Area: 41.99 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 1.71 | CX LogP: 3.83 | CX LogD: 3.83 |
Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.77 | Np Likeness Score: -1.64 |
References
1. Qiao L, Choi S, Case A, Gainer TG, Seyb K, Glicksman MA, Lo DC, Stein RL, Cuny GD.. (2009) Structure-activity relationship study of EphB3 receptor tyrosine kinase inhibitors., 19 (21): [PMID:19783434] [10.1016/j.bmcl.2009.09.010] |